Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant MVA BN RSV Vaccine

· Bavarian Nordic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant MVA BN RSV Vaccine, covering 2016-08-10 to 2016-08-10. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine [Phase 1]

See pricing